An article in the medical journal, American Family Physician, gives guidelines for treating nursing home-acquired pneumonia.
Streptococcus pneumoniae is the most common cause of nursing
home-acquired pneumonia, although Staphylococcus aureus and
gram-negative organisms may be more common in severe cases. Antibiotic
therapy for nursing home-acquired pneumonia should target a broad range
of organisms, and drug-resistant microbes should be considered when
making treatment decisions. In the nursing home setting, treatment
should consist of an antipneumococcal fluoroquinolone alone or either a
high-dose beta-lactam/beta-lactamase inhibitor or a second- or
third-generation cephalosporin, in combination with azithromycin.
Treatment of hospitalized patients with nursing home-acquired pneumonia
requires broad-spectrum antibiotics with coverage of many gram-negative
and gram-positive organisms, including methicillin-resistant S. aureus.
Appropriate dosing of antibiotics for nursing home-acquired pneumonia
is important to optimize effectiveness and avoid adverse effects.
Because many nursing home residents take multiple medications, it is
important to consider possible drug interactions.For more, see the study.
Robert W. Carter, Jr. is a Virginia attorney whose law practice is
dedicated to protecting the rights of the victims of nursing
home and assisted living neglect and abuse in Richmond, Roanoke,
Norfolk, Lynchburg, Danville, Charlottesville, and across Virginia.